Search the Newsreel

What Could MeiraGTx Holdings (MGTX) New Hires And Profit Swing Signal?

Rubric Capital discloses 9.83% MeiraGTx (MGTX) position totaling 9.1M shares

Rubric Capital Management LP and David Rosen have reported a beneficial ownership of 9.83% in MeiraGTx Holdings plc, amounting to 9,100,000 Ordinary Shares. This disclosure was made in an amended Schedule 13G filing, indicating shared voting and dispositive power over these shares, which are …

MeiraGTx (NASDAQ:MGTX) Given New $27.00 Price Target at Royal Bank Of Canada

MeiraGTx Holdings Releases Q2 2026 Financial Results

MeiraGTx Holdings plc reported a significant turnaround in Q2 2026, swinging to profitability with diluted earnings per share of $1.71, compared to a loss in the previous year. The company achieved substantial revenue growth, reaching $321.4M from $3.7M in Q2 2025, indicating a commercial …

Sei Investments Co. Buys Shares of 99,627 MeiraGTx Holdings PLC $MGTX

Sei Investments Co. has acquired 99,627 shares of MeiraGTx Holdings PLC (MGTX) worth approximately $863,000, as part of broader institutional investor interest in the company. Despite significant insider selling totaling $1.68 million over the last three months, MeiraGTx reported strong quarterly EPS of $1.71, …

MeiraGTx (NASDAQ:MGTX) Releases Quarterly Earnings Results, Beats Expectations By $2.17 EPS

Why is MeiraGTx stock surging today?

MeiraGTx Holdings PLC stock surged 6.3% following a dramatic beat on Q2 2026 earnings, reporting $1.71 EPS against an expected loss and revenue of $321.4 million. The company's financial turnaround was supported by strategic deals, FDA Breakthrough Therapy Designation, and a significantly strengthened balance …

MeiraGTx (NASDAQ:MGTX) Shares Gap Up on Strong Earnings

MeiraGTx earnings beat by $2.02, revenue topped estimates

MeiraGTx Holdings PLC (MGTX) Q2 Earnings and Revenues Surpass Estimates

MeiraGTx Holdings PLC (MGTX) reported Q2 earnings of $1.71 per share, significantly beating the Zacks Consensus Estimate of a loss of $0.39 per share, and revenue of $321.43 million, which also surpassed expectations. Despite the strong quarterly performance, the company holds a Zacks Rank …

Form 8K MeiraGTx Holdings PLC For: 13 August By Investing.com

This article reports on a Form 8K filing by MeiraGTx Holdings PLC for August 13th, as published by Investing.com. It is a brief announcement without further details regarding the content of the filing. The article is primarily a placeholder for the SEC filing information.

MeiraGTx Reports Second Quarter 2026 Financial and Operational Results

MeiraGTx Holdings plc announced its second-quarter 2026 financial and operational results, highlighting significant progress in transforming into a commercial company. Key achievements include the acquisition of botaretigene sparoparvovec (bota-vec) for XLRP, FDA Breakthrough Therapy Designation for AAV2-hAQP1 for radiation-induced xerostomia (RIX) with positive three-year …

MeiraGTx Holdings plc 2026: Revenue $321.43M, EPS $1.71— 10-Q Summary

MeiraGTx Holdings plc reported strong financial results for the 2026 quarter, with revenue soaring to $321.43 million and diluted EPS reaching $1.71. This significant growth was primarily driven by increased service and related-party revenue from a Lilly contract, as well as the recognition of …

MeiraGTx (MGTX) turns profitable on $321.7M H1 revenue and major deals

MeiraGTx GAAP EPS of $1.71 beats by $2.15, revenue of $321.4M

* MeiraGTx press release [https://seekingalpha.com/pr/20618173-meiragtx-reports-second-quarter-2026-financial-and-operational-results] (MGTX [https://seekingalpha.com/symbol/MGTX]): Q2 GAAP EPS of $1.71 beats by $2.15. * Revenue of $321.4M (+8610.0% Y/Y). MORE ON MEIRAGTX * Some Potential Merit Within MeiraGTx Holdings [https://seekingalpha.com/article/4927906-some-potential-merit-within-meiragtx-holdings] * MeiraGTx: The Market Is Missing The Manufacturing Pivot [https://seekingalpha.com/article/4918470-meiragtx-the-market-is-missing-the-manufacturing-pivot] * MeiraGTx …

MeiraGTx Reports $321.4 Million Revenue and $160.7 Million Quarterly Net Income

MeiraGTx Holdings PLC (NASDAQ:MGTX) Given Average Rating of "Moderate Buy" by Brokerages

MeiraGTx Holdings PLC (NASDAQ:MGTX) has received an average "Moderate Buy" rating from eight brokerages, with an average 12-month price target of $26.00, significantly above its current trading price of $12.96. Despite recent insider share sales by the CEO and CFO totaling $1.68 million, insiders …

MeiraGTx (MGTX) Earnings Date and Reports 2026

MeiraGTx Holdings PLC (MGTX) Stock News Today

This article from TradingKey provides stock information for MeiraGTx Holdings PLC (MGTX). It includes current stock price, market capitalization, and indicates that more news, earnings, and analyst ratings for MGTX are expected soon. The page serves as a hub for MGTX stock-related updates.

MeiraGTx Holdings plc (MGTX) Stock Analysis: Exploring a 128.97% Potential Upside in the Biotech Arena

MeiraGTx Holdings plc (NASDAQ: MGTX) is a clinical-stage biotechnology company with a market capitalization of $1.18 billion, focusing on genetic therapies for ocular, neurodegenerative, and autoimmune diseases. Analysts show strong optimism with all seven ratings being "Buy" and an average target price of $29.29, …

MeiraGTx Holdings PLC (MGTX) Earnings Forecast: Future EPS & Revenue Growth Estimates

MeiraGTx Holdings PLC (MGTX) has an earnings forecast score of 8.50, ranking 108th in the Biotechnology & Medical Research industry. Analysts have set an average price target of $27.00 for MGTX, with a "Buy" trend based on ratings from 7 analysts. The company's expected …

MeiraGTx grants new hire 75,000 stock options under inducement plan

MeiraGTx has granted a new hire 75,000 non-qualified stock options and 75,000 time-based Restricted Stock Units (RSUs) under its 2026 Employment Inducement Award Plan. The stock options are priced at the Nasdaq closing price on the employee's start date and vest over four years, …

MeiraGTx Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MeiraGTx Holdings plc announced that its Compensation Committee approved equity awards for a new employee. These awards, consisting of non-qualified stock options and time-based restricted stock units, were granted as an inducement for employment in accordance with Nasdaq Listing Rule 5635(c)(4). The grants are …

A new MeiraGTx employee receives 150,000 equity awards

MeiraGTx (Nasdaq: MGTX) announced that its Compensation Committee approved an inducement grant of 75,000 non-qualified stock options and 75,000 time-based Restricted Stock Units (RSUs) for a new employee. These awards, made under Nasdaq Listing Rule 5635(c)(4), are contingent on continued employment, with specific vesting …

MeiraGTx (MGTX) Projected to Post Earnings on Thursday

MeiraGTx Holdings PLC (328.SG) Analyst insights, Price targets and Recommendations - Yahoo Finance

The article provides an overview of analyst recommendations and price targets for MeiraGTx Holdings PLC (328.SG). It lists several recent analyst actions, including RBC Capital and HC Wainwright & Co. maintaining "Outperform" and "Buy" ratings respectively. The stock currently trades at 11.10 EUR with …

MeiraGTx Holdings (Nasdaq:MGTX) - Stock Analysis

MeiraGTx Holdings (MGTX) is a clinical-stage genetic medicines company with a market cap of US$1.1 billion. The company faces financial risks including negative shareholder equity, unprofitability, and past shareholder dilution, though revenue is forecast to grow significantly. Recent developments include a $400 million financing …

MeiraGTx Holdings PLC (MGTX) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of MeiraGTx Holdings PLC (MGTX), detailing its price momentum, support and resistance levels, and various technical indicators and moving averages. While the current price momentum score is 4.55 within the Biotechnology & Medical Research industry, technical indicators collectively …

MGTX|MeiraGTx Holdings PLC|Price:11.810|Chg%:-0.490

MeiraGTx Holdings PLC (MGTX) has a high growth potential and relatively healthy fundamentals, with its valuation considered fairly valued within the Biotechnology & Medical Research industry. The company, a clinical-stage genetic medicines firm with several late-stage clinical programs, has shown strong revenue and profit …

Price to earnings forward of MeiraGTx Holdings Plc – LS:A2JGHF

This article provides financial information for MeiraGTx Holdings Plc, identified by the stock symbol LS:A2JGHF on the Lang & Schwarz Tradecenter. It specifically focuses on the company's forward price-to-earnings ratio and indicates that the market is currently closed with no trades. The content is …

Rubric Capital Management LP Acquires 824,669 Shares of MeiraGTx Holdings PLC $MGTX

Rubric Capital Management LP increased its stake in MeiraGTx Holdings PLC by 13.4% in the first quarter, purchasing 824,669 additional shares and bringing its total holdings to 7 million shares, representing 7.56% of the company. Despite reporting a quarterly loss of $0.57 per share …

MeiraGTx Holdings PLC (MGTX) Institutional Confidence

MeiraGTx Holdings PLC (MGTX) has an institutional shareholding score of 5.00, placing it 132nd in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 59.59%, a 4.66% decrease quarter-over-quarter. Bill Nygren | OAKMX is the largest institutional shareholder, holding 62.13K shares, …

MeiraGTx Holdings PLC (MGTX) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of MeiraGTx Holdings PLC (MGTX), listing major shareholders like Sanofi SA and Perceptive Advisors LLC. It breaks down shareholder types, institutional holdings over several quarters, and recent shareholder activity including changes in positions. The piece also identifies various …